The analysis of microsatellite instability in extracolonic gastrointestinal malignancy

Pathology

Volumn 45, Issue 6, 2013, Pages 540-552

  Williams, Andrew S ^a   Huang, Weei Yuarn ^a  

^a DALHOUSIE UNIVERSITY   (Canada)

Author keywords

Colorectal neoplasms; DNA mismatch repair; Gastrointestinal neoplasms; Hereditary non polyposis; Hereditary non polyposis colorectal cancer; HNPCC; Lynch syndrome; Microsatellite instability; MSI; Replication error phenotype

Indexed keywords

BILIARY TRACT TUMOR; GENETICS; HUMAN; MICROSATELLITE INSTABILITY; PANCREAS TUMOR; PATHOLOGY; REVIEW; SMALL INTESTINE; STOMACH TUMOR;

BILIARY TRACT NEOPLASMS; HUMANS; INTESTINE, SMALL; MICROSATELLITE INSTABILITY; PANCREATIC NEOPLASMS; STOMACH NEOPLASMS;

EID: 84887943622     PISSN: 00313025     EISSN: 14653931     Source Type: Journal    
DOI: 10.1097/PAT.0b013e3283653307     Document Type: Article

References (151)

1. Shah S, Hile S, Eckert K. Defective mismatch repair, microsatellite mutation bias, and variability in clinical cancer phenotypes. Cancer Res 2010; 70: 431-5.
2. Kunkel T, Erie D. DNA mismatch repair. Annu Rev Biochem 2005; 74: 681-710.
3. Boland CR, Thibodeau SN, Hamilton SR, et al. A national cancer institute workshop on microsatellite instability for cancer detection and familial predisposition: Development of international criteria for the determination of microsatellite instability in colorectal cancer. Cancer Res 1998; 58: 5248-57.
4. Suraweera N, Duval A, Reperant M, et al. Evaluation of tumor microsatellite instability using five quasimonomorphic mononucleotide repeats and pentaplex PCR. Gastroenterology 2002; 123: 1804-11.
5. Umar A, Boland CR, Terdiman J, et al. Revised bethesda guidelines for hereditary nonpolyposis colorectal cancer (Lynch syndrome) and microsatellite instability. J Natl Cancer Inst 2004; 96: 261-8.
6. Buhard O, Suraweera N, Lectard A, Duval A, Hamelin R. Quasimonomorphic mononucleotide repeats for high-level microsatellite instability analysis. Dis Markers 2004; 20: 251-7.
7. Bacher J, Flanagan L, Smalley R, et al. Development of a fluorescent multiplex assay for detection of MSI-high tumors. Dis Markers 2004; 20: 237-50.
8. Jass Jr. Classification of colorectal cancer based on correlation of clinical, morphological and molecular features. Histopathology 2007; 50: 113-30.
9. Xicola R, Llor X, Pons E, et al. Performance of different microsatellite marker panels for detection of mismatch repair-deficient colorectal tumors. J Natl Cancer Inst 2007; 99: 244-52.
10. Murphy K, Zhang S, Geiger T, et al. Comparison of the microsatellite instability analysis system and the Bethesda panel for the determination of microsatellite instability in colorectal cancers. J Mol Diagn 2006; 8: 305- 11.
11. Vasen HF, Watson P, Mecklin JP, Lynch HT. New clinical criteria for hereditary nonpolyposis colorectal cancer (HNPCC, Lynch syndrome) proposed by the international collaborative group on HNPCC. Gastroenterology 1999; 116: 1453-6.
12. Aarnio M, Sankila R, Pukkala E, et al. Cancer risk in mutation carriers of DNA-mismatch-repair genes. Int J Cancer 1999; 81: 214-8.
13. Barrow E, Robinson L, AlduaijW, et al. Cumulative lifetime incidence of extracolonic cancers in Lynch syndrome: A report of 121 families with proven mutations. Clin Genet 2009; 75: 141-9.
14. Hitchins M. The role of epigenetics in Lynch syndrome. Fam Cancer 2013; 12: 189-205.
15. Cunningham JM, Kim CY, Christensen ER, et al. The frequency of hereditary defective mismatch repair in a prospective series of unselected colorectal carcinomas. Am J Hum Genet 2001; 69: 780-90.
16. Potocnik U, Glavac D, Golouh R, Ravnik Glavac M. Causes of microsatellite instability in colorectal tumors: Implications for hereditary nonpolyposis colorectal cancer screening. Cancer Genet Cytogenet 2001; 126: 85-96.
17. Bettstetter M, Dechant S, Ruemmele P, et al. Distinction of hereditary nonpolyposis colorectal cancer and sporadic microsatellite-unstable colorectal cancer through quantification of MLH1 methylation by real-time PCR. Clin Cancer Res 2007; 13: 3221-8.
18. Yearsley M, Hampel H, Lehman A, Nakagawa H, de la Chapelle A, Frankel W. Histologic features distinguish microsatellite-high from microsatellite-low and microsatellite-stable colorectal carcinomas, but do not differentiate germline mutations from methylation of the MLH1 promoter. Hum Pathol 2006; 37: 831-8.
19. Guastadisegni C, Colafranceschi M, Ottini L, Dogliotti E. Microsatellite instability as a marker of prognosis and response to therapy:Ameta-analysis of colorectal cancer survival data. Eur J Cancer 2010; 46: 2788-98.
20. Lawes DA, SenGupta S, Boulos PB. The clinical importance and prognostic implications of microsatellite instability in sporadic cancer. Eur J Surg Oncol 2003; 29: 201-12.
21. Aarnio M. Clinicopathological features and management of cancers in Lynch syndrome. Pathol Res Int 2012; 2012: 350309.
22. Gologan A, Sepulveda A. Microsatellite instability and DNA mismatch repair deficiency testing in hereditary and sporadic gastrointestinal cancers. Clin Lab Med 2005; 25: 179-96.
23. Shia J. Immunohistochemistry versus microsatellite instability testing for screening colorectal cancer patients at risk for hereditary nonpolyposis colorectal cancer syndrome. part I. The utility of immunohistochemistry. J Mol Diagn 2008; 10: 293-300.
24. Ruszkiewicz A, Bennett G, Moore J, et al. Correlation of mismatch repair genes immunohistochemistry and microsatellite instability status in HNPCC-associated tumours. Pathology 2002; 34: 541-7.
25. Karamurzin Y, Zeng Z, Stadler Z, et al. Unusual DNA mismatch repairdeficient tumors in Lynch syndrome: A report of new cases and review of the literature. Hum Pathol 2012; 43: 1677-87.
26. House M, Herman J, Guo M, et al. Prognostic value of hMLH1 methylation and microsatellite instability in pancreatic endocrine neoplasms. Surgery 2003; 134: 902-8.
27. Mei M, Deng D, Liu T, et al. Clinical implications of microsatellite instability and MLH1 gene inactivation in sporadic insulinomas. J Clin Endocrinol Metab 2009; 94: 3448-57.
28. Schulmann K, Brasch F, Kunstmann E, et al. HNPCC-associated small bowel cancer: Clinical and molecular characteristics. Gastroenterology 2005; 128: 590-9.
29. Arnason T, Sapp H, Rayson D, et al. Loss of expression of DNA mismatch repair proteins is rare in pancreatic and small intestinal neuroendocrine tumors. Arch Pathol Lab Med 2011; 135: 1539-44.
30. Kupka S, Haack B, Zdichavsky M, et al. Large proportion of low frequency microsatellite-instability and loss of heterozygosity in pheochromocytoma and endocrine tumors detected with an extended marker panel. J Cancer Res Clin Oncol 2008; 134: 463-71.
31. Kidd M, Eick G, Shapiro M, Camp R, Mane S, Modlin I. Microsatellite instability and gene mutations in transforming growth factor-beta type II receptor are absent in small bowel carcinoid tumors. Cancer 2005; 103: 229-36.
32. Ghimenti C, Tannergard P,Wahlberg S, et al. Microsatellite instability and mismatch repair gene inactivation in sporadic pancreatic and colon tumours. Br J Cancer 1999; 80: 11-6.
33. Kim H, An J, Noh S, Shin S, Lee Y. High microsatellite instability predicts good prognosis in intestinal-type gastric cancers. J Gastroenterol Hepatol 2011; 26: 585-92.
34. Corso G, Pedrazzani C, Marrelli D, Pascale V, Pinto E, Roviello F. Correlation of microsatellite instability at multiple loci with long-term survival in advanced gastric carcinoma. Arch Surg 2009; 144: 722-7.
35. Beghelli S, de Manzoni G, Barbi S, et al. Microsatellite instability in gastric cancer is associated with better prognosis in only stage II cancers. Surgery 2006; 139: 347-56.
36. Seo H, Chang Y, Joo S, et al. Clinicopathologic characteristics and outcomes of gastric cancers with the MSI-H phenotype. J Surg Oncol 2009; 99: 143-7.
37. Leite M, Corso G, Sousa S, et al. MSI phenotype and MMR alterations in familial and sporadic gastric cancer. Int J Cancer 2011; 128: 1606-13.
38. Gu M, Kim D, Bae Y, Choi J, Kim S, Song S. Analysis of microsatellite instability, protein expression and methylation status ofhMLH1andhMSH2 genes in gastric carcinomas. Hepatogastroenterology 2009; 56: 899-904.
39. An J, Kim H, Cheong J, Hyung W, Noh S. Microsatellite instability in sporadic gastric cancer: Its prognostic role and guidance for 5-FU based chemotherapy after R0 resection. Int J Cancer 2012; 131: 505-11.
40. Lee HS, Choi S, Lee HK, et al. Distinct clinical features and outcomes of gastric cancers with microsatellite instability. Mod Pathol 2002; 15: 632- 40.
41. Choi SW, Choi JR, Chung YJ, Kim KM, Rhyu MG. Prognostic implications of microsatellite genotypes in gastric carcinoma. Int J Cancer 2000; 89: 378-83.
42. Kim J, Shin N, Kim A, et al. Microsatellite instability status in gastric cancer: A reappraisal of its clinical significance and relationship with mucin phenotypes. Korean J Pathol 2013; 47: 28-35.
43. Falchetti M, Saieva C, Lupi R, et al. Gastric cancer with high-level microsatellite instability: Target gene mutations, clinicopathologic features, and long-term survival. Hum Pathol 2008; 39: 925-32.
44. Oliveira C, Seruca R, Seixas M, Sobrinho Simoes M. The clinicopathological features of gastric carcinomas with microsatellite instability may be mediated by mutations of different 'target genes': A study of the TGFbeta RII, IGFII R, and BAX genes. Am J Pathol 1998; 153: 1211-9.
45. Schneider BG, Bravo JC, Roa JC, et al. Microsatellite instability, prognosis and metastasis in gastric cancers from a low-risk population. Int J Cancer 2000; 89: 444-52.
46. Yamamoto H, Perez Piteira J, Yoshida T, et al. Gastric cancers of the microsatellite mutator phenotype display characteristic genetic and clinical features. Gastroenterology 1999; 116: 1348-57.
47. Oki E, Kakeji Y, Zhao Y, et al. Chemosensitivity and survival in gastric cancer patients with microsatellite instability. Ann Surg Oncol 2009; 16: 2510-5.
48. Bacani J, Zwingerman R, Di Nicola N, et al. Tumor microsatellite instability in early onset gastric cancer. J Mol Diagn 2005; 7: 465-77.
49. Kim K, Lee T, Cho N, Yang H, Kim W, Kang G. Differential clinicopathologic features in microsatellite-unstable gastric cancers with and without MLH1 methylation. Hum Pathol 2013; 44: 1055-64.
50. Arai T, Sakurai U, Sawabe M, et al. Frequent microsatellite instability in papillary and solid-type, poorly differentiated adenocarcinomas of the stomach. Gastric Cancer 2012; Dec 29: (Epub ahead of print).
51. Suzuki H, Itoh F, Toyota M, et al. Distinct methylation pattern and microsatellite instability in sporadic gastric cancer. Int J Cancer 1999; 83: 309-13.
52. Hayashi T, Arai M, Ueno M, et al. Frequency of immunohistochemical loss of mismatch repair protein in double primary cancers of the colorectum and stomach in Japan. Dis Colon Rectum 2006; 49 (Suppl): S23-9.
53. FangW, Chang S, Lan Y, et al. Microsatellite instability is associated with a better prognosis for gastric cancer patients after curative surgery.World J Surg 2012; 36: 2131-8.
54. Huang Y, Yuan Y, GeW, Hu H, Zhang S, Zheng S. Comparative features of colorectal and gastric cancers with microsatellite instability in Chinese patients. J Zhejiang Univ (Sci) B 2010; 11: 647-53.
55. Wu MS, Lee CW, Shun CT, et al. Distinct clinicopathologic and genetic profiles in sporadic gastric cancer with different mutator phenotypes. Genes Chromosomes Cancer 2000; 27: 403-11.
56. Bevilacqua RA, Simpson AJ. Methylation of the hMLH1 promoter but no hMLH1 mutations in sporadic gastric carcinomas with high-level microsatellite instability. Int J Cancer 2000; 87: 200-3.
57. van Grieken NCT, Aoyma T, Chambers PA, et al. KRAS and BRAF mutations are rare and related to DNA mismatch repair deficiency in gastric cancer from the east and the west: Results from a large international multicentre study. Br J Cancer 2013; 108: 1495-501.
58. Gylling A, Abdel Rahman WM, Juhola M, et al. Is gastric cancer part of the tumour spectrum of hereditary non-polyposis colorectal cancer? A molecular genetic study. Gut 2007; 56: 926-33.
59. Theuer C, Campbell B, Peel D, et al. Microsatellite instability in Japanese vs European American patients with gastric cancer. Arch Surg 2002; 137: 960-5.
60. Sepulveda AR, Santos AC, Yamaoka Y, et al. Marked differences in the frequency of microsatellite instability in gastric cancer from different countries. Am J Gastroenterol 1999; 94: 3034-8.
61. Buffart T, Louw M, van Grieken NCT, et al. Gastric cancers of western European and African patients show different patterns of genomic instability. BMC Med Genom 2011; 4: 7-17.
62. Watson P, Vasen HFA, Mecklin J, et al. The risk of extra-colonic, extra-endometrial cancer in the Lynch syndrome. Int J Cancer 2008; 123: 444-9.
63. Aarnio M, Mecklin JP, Aaltonen LA, Nystrom-Lahti M, Jarvinen HJ. Lifetime risk of different cancers in hereditary non-polyposis colorectal cancer (HNPCC) syndrome. Int J Cancer 1995; 64: 430-3.
64. Vasen HF, Stormorken A, Menko FH, et al. MSH2 mutation carriers are at higher risk of cancer than MLH1 mutation carriers: A study of hereditary nonpolyposis colorectal cancer families. J Clin Oncol 2001; 19: 4074-80.
65. Park YJ, Shin KH, Park JG. Risk of gastric cancer in hereditary nonpolyposis colorectal cancer in Korea. Clin Cancer Res 2000; 6: 2994-8.
66. Aarnio M, Salovaara R, Aaltonen LA, Mecklin JP, Jarvinen HJ. Features of gastric cancer in hereditary non-polyposis colorectal cancer syndrome. Int J Cancer 1997; 74: 551-5.
67. Lauren P. The two histological main types of gastric carcinoma: Diffuse and so-called intestinal-type carcinoma. An attempt at a histo-clinical classification. Acta Pathol Microbiol Scand 1965; 64: 31-49.
68. Ming SC. Gastric carcinoma. A pathobiological classification. Cancer 1977; 39: 2475-85.
69. Chiaravalli AM, Cornaggia M, Furlan D, et al. The role of histological investigation in prognostic evaluation of advanced gastric cancer. Analysis of histological structure and molecular changes compared with invasive pattern and stage. Virchows Arch 2001; 439: 158-69.
70. Pinto M, Oliveira C, Machado JC, et al. MSI-L gastric carcinomas share the hMLH1 methylation status of MSI-H carcinomas but not their clinicopathological profile. Lab Invest 2000; 80: 1915-23.
71. Pedrazzani C, Corso G, Velho S, et al. Evidence of tumor microsatellite instability in gastric cancer with familial aggregation. Fam Cancer 2009; 8: 215-20.
72. Yamazaki K, Tajima Y, Makino R, et al. Tumor differentiation phenotype in gastric differentiated-type tumors and its relation to tumor invasion and genetic alterations. World J Gastroenterol 2006; 12: 3803-9.
73. Tajima Y, Yamazaki K, Makino R, et al. Gastric and intestinal phenotypic marker expression in early differentiated-type tumors of the stomach: Clinicopathologic significance and genetic background. Clin Cancer Res 2006; 12: 6469-79.
74. Halling KC, Harper J, Moskaluk CA, et al. Origin of microsatellite instability in gastric cancer. Am J Pathol 1999; 155: 205-11.
75. Kim HS, Lee BL, Woo DK, Bae SI, Kim WH. Assessment of markers for the identification of microsatellite instability phenotype in gastric neoplasms. Cancer Lett 2001; 164: 61-8.
76. Leung SY, Yuen ST, Chung LP, Chu KM, Chan AS, Ho JC. hMLH1 promoter methylation and lack of hMLH1 expression in sporadic gastric carcinomas with high-frequency microsatellite instability. Cancer Res 1999; 59: 159-64.
77. Guo RJ, Arai H, Kitayama Y, et al. Microsatellite instability of papillary subtype of human gastric adenocarcinoma and hMLH1 promoter hypermethylation in the surrounding mucosa. Pathol Int 2001; 51: 240-7.
78. Kim HS,Woo DK, Bae SI, Kim YI, Kim WH. Microsatellite instability in the adenoma-carcinoma sequence of the stomach. Lab Invest 2000; 80: 57-64.
79. Hoang JM, Cottu PH, Thuille B, Salmon RJ, Thomas G, Hamelin R. BAT-26, an indicator of the replication error phenotype in colorectal cancers and cell lines. Cancer Res 1997; 57: 300-3.
80. Zhou XP, Hoang JM, Li YJ, et al. Determination of the replication error phenotype in human tumors without the requirement for matching normal DNA by analysis of mononucleotide repeat microsatellites. Genes Chromosomes Cancer 1998; 21: 101-7.
81. Ling Z, Tanaka A, Li P, et al. Microsatellite instability with promoter methylation and silencing of hMLH1 can regionally occur during progression of gastric carcinoma. Cancer Lett 2010; 297: 244-51.
82. Chun N, Ford J. Genetic testing by cancer site: Stomach. Cancer J 2012; 18: 355-63.
83. Roa J, Roa I, Correa P, et al. Microsatellite instability in preneoplastic and neoplastic lesions of the gallbladder. J Gastroenterol 2005; 40: 79-86.
84. Suto T, Habano W, Sugai T, et al. Infrequent microsatellite instability in biliary tract cancer. J Surg Oncol 2001; 76: 121-6.
85. Ruemmele P, Dietmaier W, Terracciano L, et al. Histopathologic features and microsatellite instability of cancers of the papilla of vater and their precursor lesions. Am J Surg Pathol 2009; 33: 691-704.
86. Iacono C, Verlato G, Zamboni G, et al. Adenocarcinoma of the ampulla of vater: T-stage, chromosome 17p allelic loss, and extended pancreaticoduodenectomy are relevant prognostic factors. J Gastrointest Surg 2007; 11: 578-88.
87. Sessa F, Furlan D, Zampatti C, Carnevali I, Franzi F, Capella C. Prognostic factors for ampullary adenocarcinomas: Tumor stage, tumor histology, tumor location, immunohistochemistry and microsatellite instability. Virchows Arch 2007; 451: 649-57.
88. Scarpa A, Di Pace C, Talamini G, et al. Cancer of the ampulla of vater: Chromosome 17p allelic loss is associated with poor prognosis. Gut 2000; 46: 842-8.
89. Achille A, Biasi MO, Zamboni G, et al. Cancers of the papilla of vater: Mutator phenotype is associated with good prognosis. Clin Cancer Res 1997; 3: 1841-7.
90. Agaram N, Shia J, Tang L, Klimstra D. DNA mismatch repair deficiency in ampullary carcinoma: A morphologic and immunohistochemical study of 54 cases. Am J Clin Pathol 2010; 133: 772-80.
91. Yanagisawa N, Mikami T, Yamashita K, Okayasu I. Microsatellite instability in chronic cholecystitis is indicative of an early stage in gallbladder carcinogenesis. Am J Clin Pathol 2003; 120: 413-7.
92. Nagai M, Kawarada Y, Watanabe M, et al. Analysis of microsatellite instability, TGF-beta type II receptor gene mutations and hMSH2 and hMLH1 allele losses in pancreaticobiliary maljunction-associated biliary tract tumors. Anticancer Res 1999; 19: 1765-8.
93. Nagai M, Watanabe M, Iwase T, Yamao K, Isaji S. Clinical and genetic analysis of noncancerous and cancerous biliary epithelium in patients with pancreaticobiliary maljunction. World J Surg 2002; 26: 91-8.
94. Sessa F, Furlan D, Genasetti A, Billo P, Feltri M, Capella C. Microsatellite instability and p53 expression in gallbladder carcinomas. Diagn Mol Pathol 2003; 12: 96-102.
95. Mishra P, Raghuram G, Jatawa S, Bhargava A, Varshney S. Frequency of genetic alterations observed in cell cycle regulatory proteins and microsatellite instability in gallbladder adenocarcinoma: A translational perspective. Asian Pac J Cancer Prev 2011; 12: 573-4.
96. Kim YT, Kim J, Jang YH, et al. Genetic alterations in gallbladder adenoma, dysplasia and carcinoma. Cancer Lett 2001; 169: 59-68.
97. Chang HJ, KimSW, KimYT, KimWH. Loss of heterozygosity in dysplasia and carcinoma of the gallbladder. Mod Pathol 1999; 12: 763-9.
98. Yoshida T, Sugai T, Habano W, et al. Microsatellite instability in gallbladder carcinoma: Two independent genetic pathways of gallbladder carcinogenesis. J Gastroenterol 2000; 35: 768-74.
99. Rashid A, Ueki T, Gao Y, et al. K-ras mutation, p53 overexpression, and microsatellite instability in biliary tract cancers: A population-based study in China. Clin Cancer Res 2002; 8: 3156-63.
100. Nagahashi M, Ajioka Y, Lang I, et al. Genetic changes of p53, K-ras, and microsatellite instability in gallbladder carcinoma in high-incidence areas of Japan and Hungary. World J Gastroenterol 2008; 14: 70-5.
101. Saetta A, Lazaris AC, Michalopoulos NV, Davaris PS. Genetic alterations involved in the development of gallbladder carcinomas from Greek patients. Hepatogastroenterology 2001; 48: 1284-8.
102. Saetta A, Koilakou S, Michalopoulos N, Davaris P. Evaluation of BAT-26 as an indicator of microsatellite instability in gallbladder carcinomas. Hepatogastroenterology 2003; 50: 1799-802.
103. Saetta A, Papanastasiou P, Michalopoulos N, et al. Mutational analysis of BRAF in gallbladder carcinomas in association with K-ras and p53 mutations and microsatellite instability. Virchows Arch 2004; 445: 179- 82.
104. Saetta A, Gigelou F, Papanastasiou P, et al. High-level microsatellite instability is not involved in gallbladder carcinogenesis. Exp Mol Pathol 2006; 80: 67-71.
105. Kim S, Chan A, Wu T, Issa J, Hamilton S, Rashid A. Epigenetic and genetic alterations in duodenal carcinomas are distinct from biliary and ampullary carcinomas. Gastroenterology 2003; 124: 1300-10.
106. Abraham S, Lee J, Boitnott J, Argani P, Furth E, Wu T. Microsatellite instability in intraductal papillary neoplasms of the biliary tract. Mod Pathol 2002; 15: 1309-17.
107. Park S, Kim S, Darwish N, Kim W. Lack of microsatellite instability in neoplasms of ampulla of vater. Pathol Int 2003; 53: 667-70.
108. Imai Y, Tsurutani N, Oda H, Inoue T, Ishikawa T. Genetic instability and mutation of the TGF-beta-receptor-II gene in ampullary carcinomas. Int J Cancer 1998; 76: 407-11.
109. Goggins M, Offerhaus GJ, Hilgers W, et al. Pancreatic adenocarcinomas with DNA replication errors (RER) are associated with wild-type K-ras and characteristic histopathology. poor differentiation, a syncytial growth pattern, and pushing borders suggest RER. Am J Pathol 1998; 152: 1501-7.
110. Nakata B, Wang Y, Yashiro M, et al. Negative hMSH2 protein expression in pancreatic carcinoma may predict a better prognosis of patients. Oncol Rep 2003; 10: 997-1000.
111. Yamamoto H, Itoh F, Nakamura H, et al. Genetic and clinical features of human pancreatic ductal adenocarcinomas with widespread microsatellite instability. Cancer Res 2001; 61: 3139-44.
112. Habbe N, Langer P, Sina Frey M, Bartsch D. Familial pancreatic cancer syndromes. Endocrinol Metab Clin North Am 2006; 35: 417-30; xi.
113. Kastrinos F, Mukherjee B, Tayob N, et al. Risk of pancreatic cancer in families with Lynch syndrome. JAMA 2009; 302: 1790-5.
114. Geary J, Sasieni P, Houlston R, et al. Gene-related cancer spectrum in families with hereditary non-polyposis colorectal cancer (HNPCC). Fam Cancer 2008; 7: 163-72.
115. Banville N, Geraghty R, Fox E, et al. Medullary carcinoma of the pancreas in a man with hereditary nonpolyposis colorectal cancer due to a mutation of the MSH2 mismatch repair gene. Hum Pathol 2006; 37: 1498-502.
116. Wilentz RE, Goggins M, Redston M, et al. Genetic, immunohistochemical, and clinical features of medullary carcinoma of the pancreas: A newly described and characterized entity. Am J Pathol 2000; 156: 1641-51.
117. Laghi L, Beghelli S, Spinelli A, et al. Irrelevance of microsatellite instability in the epidemiology of sporadic pancreatic ductal adenocarcinoma. PLoS One 2012; 7: e46002-146002.
118. Venkatasubbarao K, Ahmed MM, Swiderski C, et al. Novel mutations in the polyadenine tract of the transforming growth factor beta type II receptor gene are found in a subpopulation of human pancreatic adenocarcinomas. Genes Chromosomes Cancer 1998; 22: 138-44.
119. Maple J, Smyrk T, Boardman L, Johnson R, Thibodeau S, Chari S. Defective DNA mismatch repair in long-term (> or = years) survivors with pancreatic cancer. Pancreatology 2005; 5: 220-7.
120. Luttges J, Beyser K, Pust S, Paulus A, Ruschoff J, Kloppel G. Pancreatic mucinous noncystic (colloid) carcinomas and intraductal papillary mucinous carcinomas are usually microsatellite stable. Mod Pathol 2003; 16: 537-42.
121. Abe T, Ouyang H, Migita T, et al. The somatic mutation frequency of the transforming growth factor beta receptor type II gene varies widely among different cancers with microsatellite instability. Eur J Surg Oncol 1996; 22: 474-7.
122. Fujii K, Miyashita K, Yamada Y, et al. Simulation-based analyses reveal stable microsatellite sequences in human pancreatic cancer. Cancer Genet Cytogenet 2009; 189: 5-14.
123. Nakata B, Wang Y, Yashiro M, et al. Prognostic value of microsatellite instability in resectable pancreatic cancer. Clin Cancer Res 2002; 8: 2536-40.
124. Ouyang H, Shiwaku HO, Hagiwara H, et al. The insulin-like growth factor II receptor gene is mutated in genetically unstable cancers of the endometrium, stomach, and colorectum. Cancer Res 1997; 57: 1851-4.
125. Brentnall TA, Chen R, Lee JG, et al. Microsatellite instability and K-ras mutations associated with pancreatic adenocarcinoma and pancreatitis. Cancer Res 1995; 55: 4264-7.
126. deWilde R, Ottenhof N, Jansen M, et al. Analysis of LKB1 mutations and other molecular alterations in pancreatic acinar cell carcinoma. Mod Pathol 2011; 24: 1229-36.
127. Abraham S, Wu T, Hruban R, et al. Genetic and immunohistochemical analysis of pancreatic acinar cell carcinoma: Frequent allelic loss on chromosome 11p and alterations in the APC/beta-catenin pathway. Am J Pathol 2002; 160: 953-62.
128. Overman MJ, Pozadzides J, Kopetz S, et al. Immunophenotype and molecular characterisation of adenocarcinoma of the small intestine. Br J Cancer 2010; 102: 144-50.
129. Michel S, Kloor M, Singh S, et al. Coding microsatellite instability analysis in microsatellite unstable small intestinal adenocarcinomas identifies MARCKS as a common target of inactivation. Mol Carcinog 2010; 49: 175-82.
130. Brueckl W, Heinze E, Milsmann C, et al. Prognostic significance of microsatellite instability in curatively resected adenocarcinoma of the small intestine. Cancer Lett 2004; 203: 181-90.
131. Achille A, Baron A, Zamboni G, et al. Molecular pathogenesis of sporadic duodenal cancer. Br J Cancer 1998; 77: 760-5.
132. Potter DD, Murray J, Donohue J, et al. The role of defective mismatch repair in small bowel adenocarcinoma in celiac disease. Cancer Res 2004; 64: 7073-7.
133. Jemal A, Siegel R, Xu J,Ward E. Cancer statistics, 2010. CA Cancer J Clin 2010; 60: 277-300.
134. Engel C, Loeffler M, Steinke V, et al. Risks of less common cancers in proven mutation carriers with Lynch syndrome. J Clin Oncol 2012; 30: 4409-15.
135. Vasen HF, Wijnen JT, Menko FH, et al. Cancer risk in families with hereditary nonpolyposis colorectal cancer diagnosed by mutation analysis. Gastroenterology 1996; 110: 1020-7.
136. Rodriguez Bigas MA, Vasen HF, Lynch HT, et al. Characteristics of small bowel carcinoma in hereditary nonpolyposis colorectal carcinoma. International collaborative group on HNPCC. Cancer 1998; 83: 240-4.
137. McGregor D,Wu T, Rashid A, Luthra R, Hamilton S. Reduced expression of cytokeratin 20 in colorectal carcinomas with high levels of microsatellite instability. Am J Surg Pathol 2004; 28: 712-8.
138. Muneyuki T, Watanabe M, Yamanaka M, Isaji S, Kawarada Y, Yatani R. Combination analysis of genetic alterations and cell proliferation in small intestinal carcinomas. Dig Dis Sci 2000; 45: 2022-8.
139. Hibi K, Kondo K, Akiyama S, Ito K, Takagi H. Frequent genetic instability in small intestinal carcinomas. Japan J Cancer Res 1995; 86: 357-60.
140. Gu M, Bae Y, Kim A, et al. Expression of hMLH1, hMSH2 and hMSH6 in small intestinal carcinomas. Hepatogastroenterology 2012; 59: 2228-32.
141. Planck M, Ericson K, Piotrowska Z, Halvarsson B, Rambech E, Nilbert M. Microsatellite instability and expression of MLH1 and MSH2 in carcinomas of the small intestine. Cancer 2003; 97: 1551-7.
142. Blaker H, von Herbay A, Penzel R, Gross S, Otto H. Genetics of adenocarcinomas of the small intestine: Frequent deletions at chromosome 18q and mutations of theSMAD4 gene. Oncogene 2002; 21: 158-64.
143. Warth A, Kloor M, Schirmacher P, Blaker H. Genetics and epigenetics of small bowel adenocarcinoma: The interactions of CIN, MSI, and CIMP. Mod Pathol 2011; 24: 564-70.
144. Wheeler JMD, Warren BF, Mortensen NJM, et al. An insight into the genetic pathway of adenocarcinoma of the small intestine. Gut 2002; 50: 218-23.
145. Diosdado B, Buffart T, Watkins R, et al. High-resolution array comparative genomic hybridization in sporadic and celiac disease-related small bowel adenocarcinomas. Clin Cancer Res 2010; 16: 1391-401.
146. Bergmann F, Singh S, Michel S, et al. Small bowel adenocarcinomas in celiac disease follow the CIM-MSI pathway. Oncol Rep 2010; 24: 1535-9.
147. Rashid A, Hamilton SR. Genetic alterations in sporadic and Crohn'sassociated adenocarcinomas of the small intestine. Gastroenterology 1997; 113: 127-35.
148. Findeisen P, Kloor M, Merx S, et al. T25 repeat in the 3' untranslated region of the CASP2 gene: A sensitive and specific marker for microsatellite instability in colorectal cancer. Cancer Res 2005; 65: 8072-8.
149. Zhang M, Chen Z, Wang H. Immunohistochemical investigation of tumorigenic pathways in small intestinal adenocarcinoma: A comparison with colorectal adenocarcinoma. Mod Pathol 2006; 19: 573-80.
150. Brucher BLDM, Geddert H, Langner C, et al. Hypermethylation of hMLH1, HPP1, p14(ARF), p16(INK4A) and APC in primary adenocarcinomas of the small bowel. Int J Cancer 2006; 119: 1298-302.
151. Chan RCF, Katelaris P, Stewart P, Lin BPC. Small bowel adenocarcinoma with high levels of microsatellite instability in Crohn's disease. Hum Pathol 2006; 37: 631-4.